JAK1 and JAK3 were shown to be overexpressed in vitiligo patients’ skin compared to control skin in a stepwise manner that increased from control to non-lesional, perilesional, and lesional skin, according to Motaleb et al. Additionally, JAK3 had a significantly greater expression (43). The gene discussed is JAK1; the disease is vitiligo.